Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518973 | PMC |
| http://dx.doi.org/10.1111/jdv.17386 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ozenoxacin suppresses sebum production by inhibiting mTORC1 activation in differentiated hamster sebocytes.
J Dermatol
September 2024
Department of Biochemistry, School of Pharmacy, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Acne vulgaris is a complex condition involving factors that affect the pilosebaceous unit. A primary manifestation of acne pathology is the development of comedones, often linked to the overproduction of sebum resulting from 5α-dihydrotestosterone (5α-DHT) and insulin activity. Ozenoxacin is a topical quinolone that exhibits potent antibacterial activity against Cutibacterium acnes (C.
View Article and Find Full Text PDFCombined Nanofibrous Face Mask: Co-Formulation of Lipases and Antibiotic Agent by Electrospinning Technique.
Pharmaceutics
April 2023
Istitute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.
The application of enzyme-based therapies has received significant attention in modern drug development. Lipases are one of the most versatile enzymes that can be used as therapeutic agents in basic skin care and medical treatment related to excessive sebum production, acne, and inflammation. The traditional formulations available for skin treatment, such as creams, ointments or gels, are widely applied; however, their use is not always accompanied by good drug penetration properties, stability, or patient adherence.
View Article and Find Full Text PDFCooperative Membrane Damage as a Mechanism for Pentamidine-Antibiotic Mutual Sensitization.
ACS Chem Biol
November 2022
Institute of Chemical Biology and Nanomedicine, State Key Laboratory of Chemo/Biosensing and Chemometrics, Hunan Provincial Key Laboratory of Biomacromolecular Chemical Biology, and School of Chemistry and Chemical Engineering, Hunan University, Changsha, Hunan 410082, China.
Most Gram-positive-selective antibiotics have low activity against Gram-negative bacteria due to the presence of an outer membrane barrier. There is, therefore, interest in developing combination therapies that can penetrate the outer membrane (OM) with known antibiotics coupled with membrane-active sensitizing adjuvants. However, two unanswered questions hinder the development of such combination therapies: the sensitization spectrum of the sensitizer and the mechanism of antibiotic-sensitizer mutual potentiation.
View Article and Find Full Text PDFPotential new fluoroquinolone treatments for suspected bacterial keratitis.
BMJ Open Ophthalmol
July 2022
Department of Eye and Vision Science, University of Liverpool, Liverpool, UK
Topical fluoroquinolones (FQs) are an established treatment for suspected microbial keratitis. An increased FQ resistance in some classes of bacterial pathogens is a concern. Some recently developed FQs have an extended spectrum of activity, making them a suitable alternative for topical ophthalmic use.
View Article and Find Full Text PDFMachine Learning Enabled Structure-Based Drug Repurposing Approach to Identify Potential CYP1B1 Inhibitors.
ACS Omega
September 2022
Molecular Modeling Lab (MML), Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab 147002, India.
Article Synopsis
- Drug-metabolizing enzymes (DMEs), particularly CYP1B1, are responsible for the inactivation of several effective anticancer agents, leading to treatment failures.
- Current treatments lack approved options to counteract CYP1B1-mediated inactivation, prompting the search for new cancer therapies and potential drug repurposing strategies.
- A study utilized machine learning and virtual screening to identify compounds that inhibit CYP1B1, resulting in the selection of three promising candidates—chlorprothixene, nadifloxacin, and ticagrelor—that may help overcome drug resistance in cancer treatment.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!